Literature DB >> 21989901

Level and pattern of neuropsychological functioning in early-onset psychoses.

D-M Walker1, P J Standen.   

Abstract

The present study aimed to compare the level and pattern of cognitive deficits in patients with early-onset psychoses with an age, gender and IQ matched control group. In order to ensure a representative sample of patients with psychoses, participants with an IQ of less than 70 were included. Forty-eight patients with an onset of psychoses before the age of 16, and 47 age, gender and IQ matched controls without psychoses were recruited. Psychotic symptomatology was assessed using the Schedules for Clinical Assessment to obtain DSM-IV and ICD-10 diagnoses. Positive and negative symptoms were assessed using the Positive and Negative Symptoms Scale. Levels of cognitive function were measured using a comprehensive neuropsychological battery. A pattern of specific impairments was not found, with few significant differences between the two cohorts. However both cohort groups performed lower than age derived norms. Therefore it appears that there are global cognitive deficits rather than specific deficits in early-onset psychoses when compared to normative data, in-line with conclusions of early-onset schizophrenia research, but patients did not have greater deficit than controls when matched on IQ, gender and age, even after excluding participants with IQ less than 70.

Entities:  

Mesh:

Year:  2011        PMID: 21989901     DOI: 10.1007/s00787-011-0219-8

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  58 in total

1.  Changes over time in frontotemporal activation during a working memory task in patients with schizophrenia.

Authors:  Robert Christian Wolf; Nenad Vasic; Annett Höse; Manfred Spitzer; Henrik Walter
Journal:  Schizophr Res       Date:  2007-01-26       Impact factor: 4.939

2.  Influences on cognitive heterogeneity in schizophrenia.

Authors:  G Goldstein; W J Shemansky
Journal:  Schizophr Res       Date:  1995-12       Impact factor: 4.939

3.  A short form of the WAIS for use with the aged.

Authors:  P G Britton; R D Savage
Journal:  Br J Psychiatry       Date:  1966-04       Impact factor: 9.319

4.  The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Authors:  R S Keefe; S G Silva; D O Perkins; J A Lieberman
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

5.  Autistic children who become schizophrenic.

Authors:  L K Petty; E M Ornitz; J D Michelman; E G Zimmerman
Journal:  Arch Gen Psychiatry       Date:  1984-02

6.  The Maudsley Early-Onset Schizophrenia Study: cognitive function in adolescent-onset schizophrenia.

Authors:  Eugenia Kravariti; Robin G Morris; Sophia Rabe-Hesketh; Robin M Murray; Sophia Frangou
Journal:  Schizophr Res       Date:  2003-12-15       Impact factor: 4.939

7.  Neuropsychological functioning in adolescents with first episode psychosis: a two-year follow-up study.

Authors:  M Mayoral; A Zabala; O Robles; I Bombín; P Andrés; M Parellada; D Moreno; M Graell; O Medina; C Arango
Journal:  Eur Psychiatry       Date:  2008-04-08       Impact factor: 5.361

8.  A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia.

Authors:  R S Keefe; S E Roitman; P D Harvey; C S Blum; R L DuPre; D M Prieto; M Davidson; K L Davis
Journal:  Schizophr Res       Date:  1995-09       Impact factor: 4.939

9.  A neuropsychological study of early onset schizophrenia.

Authors:  A L Hoff; D Harris; W O Faustman; M Beal; D DeVilliers; R D Mone; J A Moses; J G Csernansky
Journal:  Schizophr Res       Date:  1996-05       Impact factor: 4.939

10.  Cognitive dysfunction in first-episode psychosis: the processing speed hypothesis.

Authors:  José Manuel Rodríguez-Sánchez; Benedicto Crespo-Facorro; Cesar González-Blanch; Rocío Perez-Iglesias; José Luis Vázquez-Barquero
Journal:  Br J Psychiatry Suppl       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.